Plain-English translation of NCT07369024 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Sickle Cell Disease research guide โPhase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether ketamine, given at a low dose through an IV, can help relieve pain in children and young adults with sickle cell disease who are experiencing a sickle cell pain crisis. You would receive the medication along with your normal pain medicine, and the study team would compare how well it works compared to standard treatment alone. The goal is to find better ways to manage the severe pain that comes with sickle cell disease.
Sickle cell disease causes sudden, severe pain crises that can be very difficult to treat with standard pain medications alone. Researchers want to know if this medication, when used as an add-on treatment, can reduce pain more effectively and help patients feel better faster during these crises.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
When you arrive at the hospital or clinic during a sickle cell pain crisis, you'll receive your standard pain medicine as usual. The study team will then give you either the new medication (ketamine) or a placebo (salt water) through your IV. The study team will watch you and ask about your pain levels at different times to see how well the treatment works. You'll be monitored during and after the treatment to make sure you're safe and comfortable.
AI-generated summary from trial data ยท Jun 6, 2026 ยท Not medical advice
United States